Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Harrold

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Irish Journal of Medical Science|March 21, 2025
An analysis of compassionate access programmes for novel oncology drugsSarah A Kelly, Karine E Ronan, Mohammed Zameer, et al.
Cancer Medicine|November 23, 2019
Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastomaJack Patrick Gleeson, Fergus Keane, Niamh M Keegan, et al.
The American Journal of Cardiology|April 5, 2016
Monitoring Ionizing Radiation Exposure for Cardiotoxic Effects of Breast Cancer TreatmentGillian Murtagh, Zoe Yu, Emily Harrold, et al.
Journal of the National Cancer Institute|May 3, 2024
Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated diseaseFergus Keane, Joanne F Chou, Henry Walch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2024
Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal CancerEmily Harrold, Fergus Keane, Henry Walch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2025
Acquired high tumor mutational burden and activity of immunotherapy after targeted therapy in microsatellite stable colorectal cancerCeline Yeh, Oliver Artz, Haochen Zhang, et al.
JAMA Oncology|September 5, 2024
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas CancerCatherine A O'Connor, Emily Harrold, David Lin, et al.
Journal of the National Cancer Institute|June 13, 2025
Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinomaFergus Keane, Lily V Saadat, Catherine A O'Connor, et al.
Journal of the National Cancer Institute|October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohortFergus Keane, Catherine O'Connor, Drew Moss, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Irish Journal of Medical Science|March 21, 2025
An analysis of compassionate access programmes for novel oncology drugsSarah A Kelly, Karine E Ronan, Mohammed Zameer, et al.
Cancer Medicine|November 23, 2019
Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastomaJack Patrick Gleeson, Fergus Keane, Niamh M Keegan, et al.
The American Journal of Cardiology|April 5, 2016
Monitoring Ionizing Radiation Exposure for Cardiotoxic Effects of Breast Cancer TreatmentGillian Murtagh, Zoe Yu, Emily Harrold, et al.
Journal of the National Cancer Institute|May 3, 2024
Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated diseaseFergus Keane, Joanne F Chou, Henry Walch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2024
Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal CancerEmily Harrold, Fergus Keane, Henry Walch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2025
Acquired high tumor mutational burden and activity of immunotherapy after targeted therapy in microsatellite stable colorectal cancerCeline Yeh, Oliver Artz, Haochen Zhang, et al.
JAMA Oncology|September 5, 2024
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas CancerCatherine A O'Connor, Emily Harrold, David Lin, et al.
Journal of the National Cancer Institute|June 13, 2025
Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinomaFergus Keane, Lily V Saadat, Catherine A O'Connor, et al.
Journal of the National Cancer Institute|October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohortFergus Keane, Catherine O'Connor, Drew Moss, et al.
Pageof 2